ICON plc, (NASDAQ: ICLR) a world-leading clinical research organisation powered by healthcare intelligence, today released ...

Chris Smyth, Ph.D., is leaving his post as president of Icon Biotech to take the helm at Comac Sept. 1, the company said in ...

Despite disappointing results during the first quarter, experts continue to have a positive outlook on ICON Public Limited ...

Headquartered in Dublin, Ireland, ICON Public ... and biotechnology companies worldwide. Despite some uncertainty driven by recent personnel changes at the Food and Drug Administration (FDA ...

Fintel reports that on April 29, 2025, JP Morgan downgraded their outlook for ICON Public Limited (NasdaqGS:ICLR) from ...

Pre-Clinical Drug Discovery Services Market to grow through 2035, driven by rising chronic diseases and increased outsourcing of early-stage R&D.

I recently bought a pack of Orbit mint gum from the library vending machine. On the edge of the packet, it said: “40% fewer ...

The demand for AI in clinical trials is experiencing strong growth, primarily fueled by the rising global prevalence of chronic illnesses like diabet ...

Fortrea forecasts revenue and EBITDA declines for 2025. With a $477.16M market cap, financial improvement could drive stock ...

From US president Donald Trump to Tesla CEO Elon Musk, Time Magazine's 100 Most Influential People of 2025 list included some of the most prominent names from around the world.

The upcoming 12th Annual Clinical Trials in Oncology conference will cover a wide range of topics on clinical research in ...